These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 5366971)
1. [Induction of an immunity against plasma cell sarcoma graft in the mouse BALB-c]. Lespinats G Eur J Cancer (1965); 1969 Nov; 5(5):421-6. PubMed ID: 5366971 [No Abstract] [Full Text] [Related]
2. [The effect of the graft-versus-host reaction on transplantation immunity to homologous tumors]. Semenkov VF; Shevelev AS Vopr Onkol; 1971; 17(6):69-73. PubMed ID: 4400328 [No Abstract] [Full Text] [Related]
3. Preliminary observations on immunity in BALB-c mice to myeloma tumor of BALB-c origin. Shearer WT; Graff RJ; Eisen HN Transplantation; 1972 Mar; 13(3):345-7. PubMed ID: 5021442 [No Abstract] [Full Text] [Related]
4. Incorporation of 125-I-iododeoxyuridine into target cells as an assay for cell immunity. Fish F; Yaakubovicz M; Witz IP J Natl Cancer Inst; 1974 Dec; 53(6):1743-7. PubMed ID: 4436870 [No Abstract] [Full Text] [Related]
5. [Experimental significance of anti-sarcoma "PT" antibodies in antineoplastic immunology in the mouse]. Ferrari S; Lucchesi M; Serafini NA Ann Ist Carlo Forlanini; 1966; 26(4):469-79. PubMed ID: 5991599 [No Abstract] [Full Text] [Related]
6. [Rejection of non viral tumors caused by infection with murine sarcoma virus]. Basombrio MA Medicina (B Aires); 1977; 37(2):127-32. PubMed ID: 197370 [No Abstract] [Full Text] [Related]
7. Studies on the kinetics of transplantation immunity. Phillips ME Cancer Res; 1966 Jan; 26(1):40-7. PubMed ID: 5322597 [No Abstract] [Full Text] [Related]
8. Immunologic enhancement in a syngeneic tumor system. Beltz WR; Levy NL Surg Forum; 1975; 26():142-4. PubMed ID: 1216091 [No Abstract] [Full Text] [Related]
9. Immunosuppression versus immunity in syngeneic and allogeneic tumours. Vlachov K; Nouza K Neoplasma; 1973; 20(1):3-12. PubMed ID: 4573871 [No Abstract] [Full Text] [Related]
10. [Proceedings: Immunity exhibited against the transplanted neoplasms by the homologous normal cells]. Nakayama M; Hosokawa M; Imamura M; Oikawa K; Kobayashi H Hokkaido Igaku Zasshi; 1975 Jan; 50(1):82-3. PubMed ID: 1171067 [No Abstract] [Full Text] [Related]
11. Tumor-specific active enhancement of a murine sarcoma. Bloom ET; Hildemann WH Tissue Antigens; 1971; 1(1):5-13. PubMed ID: 5154368 [No Abstract] [Full Text] [Related]
12. Experiments on the induction of tumor-specific resistance against isologous transplants of sarcomas induced by implantation of plastic pellets. Horn KH; Pasternak G; Graffi A Arch Immunol Ther Exp (Warsz); 1966; 14(6):737-42. PubMed ID: 5957995 [No Abstract] [Full Text] [Related]
13. The development and specific suppression of concomitant immunity in two syngeneic tumour-host systems. Chandradasa KD Int J Cancer; 1973 May; 11(3):648-62. PubMed ID: 4598551 [No Abstract] [Full Text] [Related]
14. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors. BasombrÃo MA; Prehn RT Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598 [No Abstract] [Full Text] [Related]
15. Immunogenic efficacy of various syngeneic tumor cell preparations. Natale N; Reiner J; Southam CM Cancer; 1971 Nov; 28(5):1118-25. PubMed ID: 5125660 [No Abstract] [Full Text] [Related]
16. Studies on transplantation immunity of methylcholanthrene-induced tumor by use of transplantation in lymph nodes and of diffusion chamber. Kitano M; Okada Y; Nagaishi C Exp Med Surg; 1969; 27(4):357-83. PubMed ID: 5384538 [No Abstract] [Full Text] [Related]
17. Mechanisms of tumor homograft rejection. II. Studies on the mechanism of rejection of sarcoma I ascites tumor in the C57BL-Ks mouse. Holmes B; Weiser RS J Natl Cancer Inst; 1966 May; 36(5):975-83. PubMed ID: 5939584 [No Abstract] [Full Text] [Related]
19. The effect of endotoxin on the implantation of a mouse sarcoma. Tripodi D; Hollenbeck L; Pollack W Int Arch Allergy Appl Immunol; 1970; 37(6):575-85. PubMed ID: 4903617 [No Abstract] [Full Text] [Related]
20. Complete in vivo destruction of allografted sarcoma I cells by circulating antibodies. Kinsky R; Chouroulinkov I; Voisin GA Transplantation; 1970 Nov; 10(5):450-1. PubMed ID: 5490529 [No Abstract] [Full Text] [Related] [Next] [New Search]